$PRNB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Principia Biopharma Inc.. Get notifications about new insider transactions in Principia Biopharma Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | D | 36.79 | 20,475 | 753,275 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | D | 31.77 | 20,475 | 650,491 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | D | 8.99 | 28,623 | 257,410 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Sell | U | 100.00 | 2,982,855 | 298,285,500 | 0 | 3 M to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | D | 27.81 | 20,475 | 569,410 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Sell | U | 100.00 | 667,600 | 66,760,000 | 0 | 667.6 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 4.54 | 47,724 | 216,762 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 17.00 | 55,042 | 935,714 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 11.35 | 22,017 | 250,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 7.27 | 16,843 | 122,400 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 4.54 | 30,056 | 136,514 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | U | 100.00 | 13,592 | 1,359,200 | 0 | 13.6 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Gift | G | 0.00 | 5,504 | 0 | 13,592 | 19.1 K to 13.6 K (-28.82 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | D | 23.77 | 168,057 | 3,994,715 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | U | 100.00 | 2,207 | 220,700 | 0 | 2.2 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | D | 7.27 | 11,519 | 83,710 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 1,916 | 191,600 | 0 | 1.9 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | U | 100.00 | 117,761 | 11,776,100 | 0 | 117.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 7.27 | 34,677 | 252,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 5.00 | 13,210 | 65,998 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 4.72 | 29,723 | 140,400 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 3.18 | 24,769 | 78,751 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | D | 3.00 | 56,982 | 170,815 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | U | 100.00 | 3,302 | 330,200 | 0 | 3.3 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | U | 100.00 | 3,799 | 379,900 | 0 | 3.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 67.31 | 75,000 | 5,048,250 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 7.27 | 34,677 | 252,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 22,017 | 109,999 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 15,412 | 77,000 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 8,807 | 41,601 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 13,210 | 62,399 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 3.18 | 12,960 | 41,205 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | U | 100.00 | 31,826 | 3,182,600 | 0 | 31.8 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 67.31 | 200,000 | 13,462,000 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 35.42 | 155,000 | 5,490,100 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 11.35 | 187,144 | 2,125,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 7.27 | 115,590 | 840,004 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 5.00 | 60,546 | 302,494 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 4.72 | 83,004 | 392,078 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 3.18 | 110,085 | 350,004 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 3.00 | 85,728 | 256,987 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 1.91 | 50,795 | 96,897 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | D | 8.99 | 255 | 2,293 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 18,355 | 1,835,500 | 0 | 18.4 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 39,179 | 3,917,900 | 0 | 39.2 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | U | 100.00 | 1,023 | 102,300 | 0 | 1 K to 0 (-100.00 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 7.27 | 2,242 | 16,293 | 11,519 | |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 2,758 | 13,028 | 0 | |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 99.98 | 5,000 | 499,918 | 117,761 | 122.8 K to 117.8 K (-4.07 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 7.27 | 2,242 | 16,293 | 122,761 | 120.5 K to 122.8 K (+1.86 %) |
| Sep 22 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 2,758 | 13,028 | 120,519 | 117.8 K to 120.5 K (+2.34 %) |
| Aug 20 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | M | 23.77 | 15,000 | 356,550 | 168,057 | |
| Aug 20 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | S | 100.00 | 15,000 | 1,500,000 | 1,826 | 16.8 K to 1.8 K (-89.15 %) |
| Aug 20 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Buy | M | 23.77 | 15,000 | 356,550 | 16,826 | 1.8 K to 16.8 K (+821.47 %) |
| Aug 20 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | M | 3.00 | 7,500 | 22,483 | 56,982 | |
| Aug 20 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | S | 99.37 | 7,500 | 745,240 | 3,539 | 11 K to 3.5 K (-67.94 %) |
| Aug 20 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Buy | M | 3.00 | 7,500 | 22,483 | 11,039 | 3.5 K to 11 K (+211.92 %) |
| Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 158 | 15,800 | 3,547 | |
| Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 905 | 90,500 | 20,390 | |
| Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 1,205 | 120,500 | 27,265 | |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.18 | 3,553 | 11,296 | 12,960 | |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.00 | 2,447 | 7,335 | 0 | |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 93.34 | 100 | 9,334 | 31,739 | 31.8 K to 31.7 K (-0.31 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 90.99 | 1,108 | 100,816 | 31,839 | 32.9 K to 31.8 K (-3.36 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 89.68 | 700 | 62,773 | 32,947 | 33.6 K to 32.9 K (-2.08 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 88.40 | 2,534 | 224,012 | 33,647 | 36.2 K to 33.6 K (-7.00 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 86.92 | 700 | 60,844 | 36,181 | 36.9 K to 36.2 K (-1.90 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 86.11 | 858 | 73,886 | 36,881 | 37.7 K to 36.9 K (-2.27 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.18 | 3,553 | 11,296 | 37,739 | 34.2 K to 37.7 K (+10.39 %) |
| Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.00 | 2,447 | 7,335 | 34,186 | 31.7 K to 34.2 K (+7.71 %) |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | M | 23.77 | 15,000 | 356,550 | 183,057 | |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | S | 80.07 | 15,000 | 1,201,070 | 1,826 | 16.8 K to 1.8 K (-89.15 %) |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Option Exercise | M | 23.77 | 15,000 | 356,550 | 183,057 | |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Buy | M | 23.77 | 15,000 | 356,550 | 16,826 | 1.8 K to 16.8 K (+821.47 %) |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Sell | S | 80.07 | 15,000 | 1,201,070 | 1,826 | 16.8 K to 1.8 K (-89.15 %) |
| Jul 17 2020 | PRNB | Principia Biopharm ... | Thomas Dolca | Chief Medical Offic ... | Buy | M | 23.77 | 15,000 | 356,550 | 16,826 | 1.8 K to 16.8 K (+821.47 %) |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 7,500 | 34,065 | 47,724 | |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.00 | 7,500 | 450,000 | 0 | 7.5 K to 0 (-100.00 %) |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 7,500 | 34,065 | 7,500 | 0 to 7.5 K |
| Jun 25 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Option Exercise | M | 3.00 | 15,000 | 44,966 | 85,728 | |
| Jun 25 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 62.38 | 2,502 | 156,078 | 810 | 3.3 K to 810 (-75.54 %) |
| Jun 25 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 61.82 | 11,983 | 740,745 | 3,312 | 15.3 K to 3.3 K (-78.35 %) |
| Jun 25 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Sell | S | 60.32 | 515 | 31,066 | 15,295 | 15.8 K to 15.3 K (-3.26 %) |
| Jun 25 2020 | PRNB | Principia Biopharm ... | Babler Martin | President, CEO | Buy | M | 3.00 | 15,000 | 44,966 | 15,810 | 810 to 15.8 K (+1,851.85 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 61.37 | 100 | 6,137 | 19,096 | 19.2 K to 19.1 K (-0.52 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 61.37 | 100 | 6,137 | 19,096 | 19.2 K to 19.1 K (-0.52 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 60.81 | 5,004 | 304,291 | 19,196 | 24.2 K to 19.2 K (-20.68 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 60.81 | 5,004 | 304,291 | 19,196 | 24.2 K to 19.2 K (-20.68 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 59.89 | 400 | 23,957 | 24,200 | 24.6 K to 24.2 K (-1.63 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 59.89 | 400 | 23,957 | 24,200 | 24.6 K to 24.2 K (-1.63 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 5,000 | 23,618 | 2,758 | |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 62.13 | 863 | 53,617 | 117,761 | 118.6 K to 117.8 K (-0.73 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 61.62 | 2,542 | 156,630 | 118,624 | 121.2 K to 118.6 K (-2.10 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 59.90 | 1,595 | 95,541 | 121,166 | 122.8 K to 121.2 K (-1.30 %) |
| Jun 15 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 5,000 | 23,618 | 122,761 | 117.8 K to 122.8 K (+4.25 %) |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Tomasello Shawn | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Machado Patrick | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Lin Shao-Lee | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| May 21 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Option Exercise | M | 3.00 | 5,675 | 17,012 | 64,482 | |
| May 21 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Sell | S | 65.10 | 7,500 | 488,268 | 3,539 | 11 K to 3.5 K (-67.94 %) |
| May 21 2020 | PRNB | Principia Biopharm ... | CHAI CHRISTOPHER Y | Chief Financial Off ... | Buy | M | 3.00 | 5,675 | 17,012 | 11,039 | 5.4 K to 11 K (+105.80 %) |
| May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.00 | 6,000 | 17,986 | 2,447 | |
| May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 60.39 | 2,719 | 164,207 | 30,968 | 33.7 K to 31 K (-8.07 %) |
| May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 59.96 | 3,281 | 196,734 | 33,687 | 37 K to 33.7 K (-8.88 %) |
| May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.00 | 6,000 | 17,986 | 36,968 | 31 K to 37 K (+19.37 %) |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 6,660 | 30,250 | 55,224 | |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 840 | 3,815 | 61,884 | |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.00 | 6,660 | 399,600 | 0 | 6.7 K to 0 (-100.00 %) |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 6,660 | 30,250 | 6,660 | 0 to 6.7 K |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.07 | 840 | 50,457 | 0 | 840 to 0 (-100.00 %) |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 840 | 3,815 | 840 | 0 to 840 |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | M | 4.54 | 5,504 | 24,999 | 19,047 | |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 46.36 | 3,750 | 173,838 | 35,609 | 39.4 K to 35.6 K (-9.53 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 45.72 | 1,754 | 80,192 | 39,359 | 41.1 K to 39.4 K (-4.27 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Buy | M | 4.54 | 5,504 | 24,999 | 41,113 | 35.6 K to 41.1 K (+15.46 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Option Exercise | M | 4.72 | 5,000 | 23,618 | 7,758 | |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 51.04 | 100 | 5,104 | 116,903 | 117 K to 116.9 K (-0.09 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 49.46 | 1,181 | 58,408 | 117,003 | 118.2 K to 117 K (-1.00 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Sell | S | 48.21 | 3,719 | 179,304 | 118,184 | 121.9 K to 118.2 K (-3.05 %) |
| Mar 17 2020 | PRNB | Principia Biopharm ... | Hardiman Roy C. | Chief Business Offi ... | Buy | M | 4.72 | 5,000 | 23,618 | 121,903 | 116.9 K to 121.9 K (+4.28 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 |